Investor insights
Sectors invested in
Epstein-Barr Virus1
Biopharma1
Therapeutics1
Health Care1
Pharmaceutical1
Biotechnology1
Lymphoproliferative Disorders1
Breast Cancer1
Gastric Cancer1
Immuno-Oncology1
Medical1
lymphoma1
Funding rounds participated in
$18M sweet spot round size
Most of their 1 investments are in rounds between $18M and $18M
Basic info
Industry
biotechnology research
Sectors
Biotechnology
Health Care
Natural Killer Cells
Immunotherapy
Oncology
Pharmaceutical
Cancer
Date founded
2002
Investments made
V
Viracta Therapeutics, Inc. raised $18M on April 4, 2017
Investors: Forward Ventures and NantKwest (NASDAQ: NK)